Your session is about to expire
← Back to Search
panobinostat capsules for Multiple Myeloma (PANORAMA_3 Trial)
PANORAMA_3 Trial Summary
This trial is investigating the safety and efficacy of three different regimens of PAN (20 mg TIW, 20 mg BIW, and 10 mg TIW) in combination with s.c. BTZ and Dex to find the optimal regimen of PAN.
- Multiple Myeloma
PANORAMA_3 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPANORAMA_3 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PANORAMA_3 Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has the FDA sanctioned bortezomib injection?
"Given its status as a Phase 2 trial, with some evidence of safety but no data supporting efficacy, bortezomib injection received an overall score of 2."
How many venues are administering this experiment?
"At this time, 11 trial locations are actively enrolling patients. These sites span from Kitchener to Atlanta and Edmonton with other convenient spots throughout the country. To reduce travel needs while partaking in the study, make sure you select a nearby centre."
What other explorations have been done with bortezomib injection?
"Bortezomib injection was first tested in 2002 at Manitoba Blood & Marrow Transplant Program CancerCare Manitoba, and has since been the subject of 1435 completed medical trials. At present, 603 clinical trials are actively recruiting patients; a significant proportion of these studies taking place in Kitchener, Ontario."
For what conditions is bortezomib injection typically prescribed?
"Bortezomib injections have the capacity to treat ophthalmic, sympathetic, and eye-related conditions such as branch retinal vein occlusion."
Is enrollment for this experiment open at present?
"Unfortunately, this research effort is not enrolling patients at present. Although first posted on April 27th 2016 and recently updated on March 15th 2021, it has yet to resume recruitment of subjects. However, there are presently 807 clinical trials searching for individuals with multiple myeloma and 603 recruiting those in need of bortezomib injections."
How many participants is this medical experiment currently treating?
"Recruitment for this trial has ended. Initially posted on April 27th, 2016 and last updated March 15th 2021; if you are looking for an alternative research opportunity there are presently 807 multiple myeloma studies and 603 bortezomib injection trials accepting applicants."
Share this study with friends
Copy Link
Messenger